Missed Opportunity: Would PGx Have Helped Sanofi-Aventis Avoid Phase III Failure for Iniparib?

Currently, there is no publicly announced companion diagnostic collaboration between Sanofi and Myriad for iniparib. However, Myriad plans to reach out to Sanofi to gauge the drugmaker's interest in doing a retrospective trial using BRACAnalysis.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.